The Patent Finder
US

Misuse Preventative, Controlled Release Formulation

US 8,920,834 In force
OverviewFamilyAssignmentsSources & methods

Term ends Dec 16, 2028 · High confidence

Filed Jun 16, 2014 as application 14/305,895 · Granted Dec 30, 2014
Base term, 20 years from filing
Today
20 years from filing
2008 2028
Clock starts
Dec 16, 2008
Term ends
Dec 16, 2028
Granted
Dec 30, 2014
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,486,448, US 8,486,449, US 8,685,447, US 8,691,270, US 8,920,833, US 8,927,013, US 8,927,014, to Dec 16, 2028. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 16, 2008, when application 12/336,495, the earliest non-provisional in its chain, was filed (this one was filed Jun 16, 2014)Dec 16, 2028High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,486,448, US 8,486,449, US 8,685,447, US 8,691,270, US 8,920,833, US 8,927,013, US 8,927,014)resolves to Dec 16, 2028, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderDec 16, 2028High confidence

This family

US 8,486,448In force
Dec 2029
Dec 2029
US 8,691,270Lapsed on the fee record
Apr 2026
Apr 2026
US 8,920,833In force
Dec 2028
Dec 2028
US 8,920,834this patent
Dec 2028
Dec 2028
Application 14/560,886Abandoned
not computed
not computed
Application 15/004,471Abandoned
not computed
not computed
Application 15/700,842Abandoned
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 26, 2020
Reel 53548, frame 239
Endo Global Ventures; Endo Ventures Limited; Paladin Labs Inc.Wilmington Trust, National AssociationConfirmatory Grant of Security Interest in United States Patents
Sep 17, 2021
Reel 57538, frame 893
Endo Ventures Limited; Endo Global Ventures; Paladin Labs Inc.Wilmington Trust, National AssociationConfirmatory Grant of Security Interest in United States Patents
Mar 5, 2024
Reel 66732, frame 137
Endo Ventures Unlimited CompanyOperand Pharmaceuticals III LimitedAssignment of Assignor's Interest
Mar 5, 2024
Reel 66732, frame 396
Endo Ventures LimitedEndo Ventures Unlimited CompanyChange of Name
Mar 5, 2024
Reel 66732, frame 413
Operand Pharmaceuticals III LimitedEndo Operations LimitedChange of Name
Apr 23, 2024
Reel 67203, frame 281
Paladin Labs Inc.Paladin Pharma Inc.Assignment of Assignor's Interest
Apr 24, 2024
Reel 67216, frame 376
Wilmington Trust, National AssociationEndo Global Aesthetics Limited; Endo Global Ventures; Endo Ventures Bermuda Limited; Endo Ventures Limited; Paladin Labs Inc.Release of Security Interest
Apr 24, 2024
reel/frame not recorded
Wilmington Trust, National AssociationEndo Global Aesthetics LimitedRelease of Security Interest
Apr 24, 2024
reel/frame not recorded
Wilmington Trust, National AssociationEndo Global VenturesRelease of Security Interest
Apr 24, 2024
reel/frame not recorded
Wilmington Trust, National AssociationEndo Ventures Bermuda LimitedRelease of Security Interest
Apr 24, 2024
reel/frame not recorded
Wilmington Trust, National AssociationEndo Ventures LimitedRelease of Security Interest
Apr 24, 2024
reel/frame not recorded
Wilmington Trust, National AssociationPaladin Labs Inc.Release of Security Interest
Apr 25, 2024
Reel 67221, frame 958
Wilmington Trust, National AssociationEndo Global Aesthetics Limited; Endo Global Ventures; Endo Ventures Bermuda Limited; Endo Ventures Limited; Paladin Labs Inc.Release of Security Interest
Apr 25, 2024
reel/frame not recorded
Wilmington Trust, National AssociationEndo Global Aesthetics LimitedRelease of Security Interest
Apr 25, 2024
reel/frame not recorded
Wilmington Trust, National AssociationEndo Global VenturesRelease of Security Interest
Apr 25, 2024
reel/frame not recorded
Wilmington Trust, National AssociationEndo Ventures Bermuda LimitedRelease of Security Interest
Apr 25, 2024
reel/frame not recorded
Wilmington Trust, National AssociationEndo Ventures LimitedRelease of Security Interest
Apr 25, 2024
reel/frame not recorded
Wilmington Trust, National AssociationPaladin Labs Inc.Release of Security Interest
Apr 27, 2024
Reel 67245, frame 714
Paladin Pharma Inc.Endo Operations LimitedAssignment of Assignor's Interest
Jun 20, 2024
Reel 67778, frame 988
Paladin Labs (Barbados) Inc.Endo Ventures Unlimited Company (F/K/A Endo Ventures Limited)Assignment of Assignor's Interest
Jun 20, 2024
Reel 67779, frame 54
Paladin Labs Europe LimitedEndo Ventures Unlimited Company (F/K/A Endo Ventures Limited)Assignment of Assignor's Interest
Jun 20, 2024
Reel 67994, frame 211
Endo Ventures LimitedEndo Ventures Unlimited CompanyChange of Name
Jul 19, 2024
Reel 68461, frame 692
Endo Biologics Limited; Endo Operations LimitedGoldman Sachs Bank USASecurity Interest
Jul 19, 2024
Reel 68031, frame 59
Endo Operations LimitedGoldman Sachs Bank USA, as Collateral AgentSecurity Interest
Jul 19, 2024
Reel 68031, frame 202
Endo Operations LimitedComputershare Trust Company, National AssociationSecurity Interest
Jul 22, 2024
Reel 68469, frame 1
Endo Biologics Limited; Endo Operations LimitedComputershare Trust Company, National AssociationSecurity Interest
Apr 17, 2025
Reel 70887, frame 702
Paladin Pharma Inc.Endo Operations LimitedCorrective Assignment to Correct the Application Number Previously Recorded at Reel: 67245 Frame: 714. Assignor(S) Hereby Confirms the Assignment.
Jul 23, 2025
Reel 71804, frame 377
Computershare Trust Company, National AssociationEndo Operations LimitedRelease of Security Interest
Jul 23, 2025
Reel 71804, frame 384
Goldman Sachs Bank USAEndo Operations LimitedRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited